Market By Age Group, Education, Drugs & Devices, End Users And Geography | Forecast 2019-2027
According to Triton, the global contraceptives market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 6.93%. The market was assessed to be worth $24280.09 million in the year 2018 and is predicted to generate a revenue of approximately $44040.80 million by the year 2027.
The increase in the use of modern contraceptive methods, rising awareness about sexual health & family planning and an increase in government initiatives are likely to drive the market during the forecast period. Healthcare providers are imparting education about contraceptive options and their advantages, disadvantages, availability, accuracy and price to provide users with the option to select the best contraceptive technique, which depends largely on their desired family size, lifestyle, desire for children and envisioned scheduling for pregnancy.
Report Scope Can Be Customized Per Your Requirements. Request for Customization
Contraceptive devices are expected to witness lucrative growth owing to associated advantages such as fewer side effects and effective contraception. Condoms have been determined to be the most profitable sub-segment of the contraceptive devices market. Low prices and abundant product availability are two key factors expected to drive the segment growth over the forecast period. Market definition and key insights regarding the industry have been discussed within this report. Also, the regulatory framework, market attractiveness index, Porter’s five force analysis and key market strategies have been studied for the global contraceptive market.
Market drivers comprise of growing cognizance for contraceptives, increasing usage of oral contraceptives to evade unplanned pregnancy, surge in the initiatives of the government and NGOs and growing awareness about STDs. The industry is facing market restraints like side-effects restricting the growth of contraceptives and limited access to contraceptives that obstructs the usage of contraceptives.
Key opportunities like rising disposable incomes in emerging economies, unmet medical needs in the emerging economies and technological advancements create an opportunity for the contraceptive market. Female and male contraceptive methods have witnessed technological advancements, which are anticipated to drive the contraceptives market growth in the future.
Lack of acceptance in society is a major barrier for the contraceptives market. The socio-cultural restrictions hamper the market growth, as these are the basic beliefs of the elderly population in a few emerging economies.
To Get Detailed Insights on Segments, Download Sample Report
Geographies that have been studied in the global contraceptive market are as follows:
• North America: The United States and Canada
• Europe: The United Kingdom, Germany, France, Italy, Spain, Russia and rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and rest of Asia-Pacific
• Latin America: Brazil, Mexico and rest of Latin America
• The Middle East & Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and rest of the Middle East & Africa
The report on the global contraceptive market includes segmentation on the basis of age group, education, drugs & devices and end users.
O Age group is segmented into:
• 15–24 years
• 25–34 years
• 35–44 years
• Above 44 years
O Education is segmented into:
• Less than high school
• High school graduate
• College graduate
• Other college degrees
O Drugs & devices are segmented into:
• Contraceptives drugs:
O Oral contraceptive pills
O Injectable contraceptives
O Topical contraceptives
• Contraceptive devices:
O Male condoms
O Female condoms
O Diaphragms
O Contraceptive sponges
O Vaginal rings
O Subdermal implants
O Intra-uterine devices:
• Copper intra-uterine devices
• Hormonal intra-uterine devices
O End users are segmented into:
• Households
• Clinics
• Hospitals
The companies engaged in the global contraceptive market are Church & Dwight Co., Inc., Agile Therapeutics, Allergan, Inc., Reckitt Benckiser PLC, SMB Corporation, Mayer Laboratories, Inc., Afaxys, Inc., Ocon Medical, Ltd., Teva Pharmaceutical Industries, Ltd., Bayer AG, Pfizer, Inc., Melbea, Cooper Surgical, Inc., Apothecus Pharmaceutical Corporation, Okamoto Industries, Inc., Pregna and Merck & Co., Inc.
The strategic analysis for each of these companies in the global contraceptive market has been covered in detail. The company market position helps to dive into the information about the key market players in this industry and how much of a hold they have on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. CONTRACEPTIVE
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. REGULATORY
OUTLOOK
2.4. PESTEL
OUTLOOK
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. MARKET
PLAYER POSITIONING
2.7. KEY
INSIGHTS
2.7.1. ORAL
CONTRACEPTIVE ARE THE MAJORLY USED CONTRACEPTIVE DRUGS
2.7.2. CONDOMS
ARE THE WIDELY USED CONTRACEPTIVES DEVICE
2.7.3. AGE
GROUP OF 15–24 YEARS ARE THE MAJOR REVENUE CONTRIBUTORS TO THE GLOBAL
CONTRACEPTIVE MARKET
2.8. MARKET
DRIVERS
2.8.1. GROWING
COGNIZANCE FOR CONTRACEPTIVES
2.8.2. INCREASING
USAGE OF ORAL CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY
2.8.3. SURGE
IN THE INITIATIVES OF GOVERNMENT AND NGO
2.8.4. GROWING
AWARENESS ABOUT STD
2.9. MARKET
RESTRAINTS
2.9.1. SIDE
EFFECTS RESTRICTING THE GROWTH OF CONTRACEPTIVES
2.9.2. LIMITED
ACCESS TO CONTRACEPTIVES
2.10.
MARKET OPPORTUNITIES
2.10.1.
RISING DISPOSABLE INCOME IN
EMERGING ECONOMIES
2.10.2.
UNMET MEDICAL NEEDS IN THE
EMERGING ECONOMIES
2.10.3.
TECHNOLOGICAL ADVANCEMENTS
2.11.
MARKET CHALLENGES
2.11.1.
LACK OF ACCEPTANCE OF SOCIETY
3. CONTRACEPTIVE
MARKET OUTLOOK - BY EDUCATION
3.1. LESS
THAN HIGH SCHOOL
3.2. HIGH
SCHOOL GRADUATE
3.3. COLLEGE
GRADUATE
3.4. OTHER
COLLEGE DEGREES
4. CONTRACEPTIVE
MARKET OUTLOOK - BY AGE GROUP
4.1. 15–24
YEARS
4.2. 25–34
YEARS
4.3. 35–44
YEARS
4.4. ABOVE
44 YEARS
5. CONTRACEPTIVE
MARKET OUTLOOK - BY END USER
5.1. HOUSEHOLDS
5.2. CLINICS
5.3. HOSPITALS
6. CONTRACEPTIVE
MARKET OUTLOOK - BY DRUGS AND DEVICES
6.1. CONTRACEPTIVES
DRUGS
6.1.1. ORAL
CONTRACEPTIVE PILLS
6.1.2. INJECTABLE
CONTRACEPTIVES
6.1.3. TOPICAL
CONTRACEPTIVES
6.2. CONTRACEPTIVE
DEVICES
6.2.1. MALE
CONDOMS
6.2.2. FEMALE
CONDOMS
6.2.3. DIAPHRAGMS
6.2.4. CONTRACEPTIVE
SPONGES
6.2.5. VAGINAL
RINGS
6.2.6. SUBDERMAL
IMPLANTS
6.2.7. INTRA-UTERINE
DEVICES
6.2.7.1. COPPER
INTRA-UTERINE DEVICES
6.2.7.2. HORMONAL
INTRA-UTERINE DEVICES
7. CONTRACEPTIVE
MARKET - REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY EDUCATION
7.1.2. MARKET
BY AGE GROUP
7.1.3. MARKET
BY END USER
7.1.4. MARKET
BY DRUGS & DEVICES
7.1.4.1. MARKET
BY DRUGS
7.1.4.2. MARKET
BY DEVICES
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. THE
UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET
BY EDUCATION
7.2.2. MARKET
BY AGE GROUP
7.2.3. MARKET
BY END USER
7.2.4. MARKET
BY DRUGS & DEVICES
7.2.4.1. MARKET
BY DRUGS
7.2.4.2. MARKET
BY DEVICES
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. FRANCE
7.2.5.3. THE
UNITED KINGDOM
7.2.5.4. SPAIN
7.2.5.5. ITALY
7.2.5.6. RUSSIA
7.2.5.7. REST
OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY EDUCATION
7.3.2. MARKET
BY AGE GROUP
7.3.3. MARKET
BY END USER
7.3.4. MARKET
BY DRUGS & DEVICES
7.3.4.1. MARKET
BY DRUGS
7.3.4.2. MARKET
BY DEVICES
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. JAPAN
7.3.5.2. CHINA
7.3.5.3. INDIA
7.3.5.4. AUSTRALIA
& NEW ZEALAND
7.3.5.5. SOUTH
KOREA
7.3.5.6. ASEAN
COUNTRIES
7.3.5.7. REST
OF ASIA-PACIFIC
7.4. LATIN
AMERICA
7.4.1. MARKET
BY EDUCATION
7.4.2. MARKET
BY AGE GROUP
7.4.3. MARKET
BY END USER
7.4.4. MARKET
BY DRUGS & DEVICES
7.4.4.1. MARKET
BY DRUGS
7.4.4.2. MARKET
BY DEVICES
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST
OF LATIN AMERICA
7.5. THE
MIDDLE EAST AND AFRICA
7.5.1. MARKET
BY EDUCATION
7.5.2. MARKET
BY AGE GROUP
7.5.3. MARKET
BY END USER
7.5.4. MARKET
BY DRUGS & DEVICES
7.5.4.1. MARKET
BY DRUGS
7.5.4.2. MARKET
BY DEVICES
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. UNITED
ARAB EMIRATES
7.5.5.2. TURKEY
7.5.5.3. SAUDI
ARABIA
7.5.5.4. SOUTH
AFRICA
7.5.5.5. REST
OF THE MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. COMPANY
PROFILES
8.1.1. ALLERGAN
INC.
8.1.2. BAYER
AG
8.1.3. MELBEA
8.1.4. PREGNA
8.1.5. PFIZER,
INC.
8.1.6. CHURCH
& DWIGHT CO., INC.
8.1.7. AFAXYS,
INC.
8.1.8. APOTHECUS
PHARMACEUTICAL CORPORATION
8.1.9. COOPER
SURGICAL INC
8.1.10.
OKAMOTO INDUSTRIES, INC
8.1.11.
MAYER LABORATORIES, INC.
8.1.12.
AGILE THERAPEUTICS
8.1.13.
MERCK & CO., INC.
8.1.14.
RECKITT BENCKISER PLC
8.1.15.
SMB CORPORATION
8.1.16.
TEVA PHARMACEUTICAL INDUSTRIES
LTD.
8.1.17.
OCON MEDICAL LTD
9. METHODOLOGY
& SCOPE
9.1. RESEARCH
SCOPE
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1 GLOBAL CONTRACEPTIVE MARKET BY REGION
2019-2027 ($ MILLION)
TABLE 2 CONTRACEPTIVE MARKET PLAYER POSITIONING OUTLOOK 2017
TABLE 3 GLOBAL CONTRACEPTIVE MARKET BY EDUCATION
2019-2027 ($ MILLION)
TABLE 4 GLOBAL CONTRACEPTIVE MARKET BY AGE GROUP
2019-2027 ($ MILLION)
TABLE 5 GLOBAL CONTRACEPTIVE MARKET BY END USER
2019-2027 ($ MILLION)
TABLE 6 GLOBAL CONTRACEPTIVE MARKET BY DRUGS AND
DEVICES 2019-2027 ($ MILLION)
TABLE 7 GLOBAL CONTRACEPTIVES DRUGS MARKET BY
TYPE 2019-2027 ($ MILLION)
TABLE 8 GLOBAL CONTRACEPTIVE DEVICES MARKET BY
TYPE 2019-2027 ($ MILLION)
TABLE 9 GLOBAL INTRA-UTERINE DEVICES MARKET BY
TYPE 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA CONTRACEPTIVE MARKET BY
COUNTRY 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA CONTRACEPTIVE MARKET BY
EDUCATION 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA CONTRACEPTIVE MARKET BY AGE
GROUP 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA CONTRACEPTIVE MARKET BY END
USER 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA CONTRACEPTIVE MARKET BY
DRUGS & DEVICES 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA CONTRACEPTIVE MARKET BY
DRUGS 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA CONTRACEPTIVE MARKET BY
DEVICES 2019-2027 ($ MILLION)
TABLE 17 EUROPE CONTRACEPTIVE MARKET BY COUNTRY
2019-2027 ($ MILLION)
TABLE 18 EUROPE CONTRACEPTIVE MARKET BY EDUCATION
2019-2027 ($ MILLION)
TABLE 19 EUROPE CONTRACEPTIVE MARKET BY AGE GROUP
2019-2027 ($ MILLION)
TABLE 20 EUROPE CONTRACEPTIVE MARKET BY END USER
2019-2027 ($ MILLION)
TABLE 21 EUROPE CONTRACEPTIVE MARKET BY DRUGS &
DEVICES 2019-2027 ($ MILLION)
TABLE 22 EUROPE CONTRACEPTIVE MARKET BY DRUGS
2019-2027 ($ MILLION)
TABLE 23 EUROPE CONTRACEPTIVE MARKET BY DEVICES
2019-2027 ($ MILLION)
TABLE 24 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
COUNTRY 2019-2027 ($ MILLION)
TABLE 25 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
EDUCATION 2019-2027 ($ MILLION)
TABLE 26 ASIA-PACIFIC CONTRACEPTIVE MARKET BY AGE
GROUP 2019-2027 ($ MILLION)
TABLE 27 ASIA-PACIFIC CONTRACEPTIVE MARKET BY END
USER 2019-2027 ($ MILLION)
TABLE 28 ASIA-PACIFIC CONTRACEPTIVE MARKET BY DRUGS
& DEVICES 2019-2027 ($ MILLION)
TABLE 29 ASIA PACIFIC CONTRACEPTIVE MARKET BY DRUGS
2019-2027 ($ MILLION)
TABLE 30 ASIA PACIFIC CONTRACEPTIVE MARKET BY
DEVICES 2019-2027 ($ MILLION)
TABLE 31 LATIN AMERICA CONTRACEPTIVE MARKET BY
COUNTRY 2019-2027 ($ MILLION)
TABLE 32 LATIN AMERICA CONTRACEPTIVE MARKET BY
EDUCATION 2019-2027 ($ MILLION)
TABLE 33 LATIN AMERICA CONTRACEPTIVE MARKET BY AGE
GROUP 2019-2027 ($ MILLION)
TABLE 34 LATIN AMERICA CONTRACEPTIVE MARKET BY END
USER 2019-2027 ($ MILLION)
TABLE 35 LATIN AMERICA CONTRACEPTIVE MARKET BY
DRUGS & DEVICES 2019-2027 ($ MILLION)
TABLE 36 LATIN AMERICA CONTRACEPTIVE MARKET BY
DRUGS 2019-2027 ($ MILLION)
TABLE 37 LATIN AMERICA CONTRACEPTIVE MARKET BY DEVICES
2019-2027 ($ MILLION)
TABLE 38 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 39 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY EDUCATION 2019-2027 ($ MILLION)
TABLE 40 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY AGE GROUP 2019-2027 ($ MILLION)
TABLE 41 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 42 THE MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)
TABLE 43 MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY DRUGS 2019-2027 ($ MILLION)
TABLE 44 MIDDLE EAST AND AFRICA CONTRACEPTIVE
MARKET BY DEVICES 2019-2027 ($ MILLION)
FIGURE 1 GLOBAL CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 2 PORTER’S FIVE FORCE MODEL
FIGURE 3 GLOBAL CONTRACEPTIVE MARKET BY LESS THAN
HIGH SCHOOL 2019-2027 ($ MILLION)
FIGURE 4 GLOBAL CONTRACEPTIVE MARKET BY HIGH SCHOOL
GRADUATE 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL CONTRACEPTIVE MARKET BY COLLEGE GRADUATE
2019-2027 ($ MILLION)
FIGURE 6 GLOBAL CONTRACEPTIVE MARKET BY OTHER
COLLEGE DEGREES 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL CONTRACEPTIVE MARKET BY 15–24 YEARS
2019-2027 ($ MILLION)
FIGURE 8 GLOBAL CONTRACEPTIVE MARKET BY 25–34 YEARS
2019-2027 ($ MILLION)
FIGURE 9 GLOBAL CONTRACEPTIVE MARKET BY 35–44 YEARS
2019-2027 ($ MILLION)
FIGURE 10 GLOBAL CONTRACEPTIVE MARKET BY ABOVE 44 YEARS
2019-2027 ($ MILLION)
FIGURE 11 GLOBAL CONTRACEPTIVE MARKET BY HOUSEHOLDS
2019-2027 ($ MILLION)
FIGURE 12 GLOBAL CONTRACEPTIVE MARKET BY CLINICS
2019-2027 ($ MILLION)
FIGURE 13 GLOBAL CONTRACEPTIVE MARKET BY HOSPITALS
2019-2027 ($ MILLION)
FIGURE 14 GLOBAL CONTRACEPTIVE MARKET BY CONTRACEPTIVES
DRUGS 2019-2027 ($ MILLION)
FIGURE 15 GLOBAL CONTRACEPTIVES DRUGS MARKET BY ORAL
CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)
FIGURE 16 GLOBAL CONTRACEPTIVES DRUGS MARKET BY
INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 17 GLOBAL CONTRACEPTIVES DRUGS MARKET BY TOPICAL
CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL CONTRACEPTIVE MARKET BY CONTRACEPTIVE
DEVICES 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL CONTRACEPTIVE DEVICES MARKET BY MALE
CONDOMS 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL CONTRACEPTIVE DEVICES MARKET BY FEMALE
CONDOMS 2019-2027 ($ MILLION)
FIGURE 21 GLOBAL CONTRACEPTIVE DEVICES MARKET BY
DIAPHRAGMS 2019-2027 ($ MILLION)
FIGURE 22 GLOBAL CONTRACEPTIVE DEVICES MARKET BY
CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)
FIGURE 23 GLOBAL CONTRACEPTIVE DEVICES MARKET BY
VAGINAL RINGS 2019-2027 ($ MILLION)
FIGURE 24 GLOBAL CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL
IMPLANTS 2019-2027 ($ MILLION)
FIGURE 25 GLOBAL CONTRACEPTIVE DEVICES MARKET BY
INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 26 GLOBAL INTRA-UTERINE DEVICES MARKET BY COPPER
INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 27 GLOBAL INTRA-UTERINE DEVICES MARKET BY
HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 28 THE UNITED STATES CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 29 CANADA CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 30 GERMANY CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 31 FRANCE CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 32 THE UNITED KINGDOM CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 33 SPAIN CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 34 ITALY CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 35 RUSSIA CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 36 REST OF EUROPE CONTRACEPTIVE MARKET 2019-2027
($ MILLION)
FIGURE 37 JAPAN CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 38 CHINA CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 39 INDIA CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 40 AUSTRALIA & NEW ZEALAND CONTRACEPTIVE
MARKET 2019-2027 ($ MILLION)
FIGURE 41 SOUTH KOREA CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 42 ASEAN COUNTRIES CONTRACEPTIVE MARKET 2019-2027
($ MILLION)
FIGURE 43 REST OF ASIA-PACIFIC CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 44 BRAZIL CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 45 MEXICO CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 46 REST OF LATIN AMERICA CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 47 UNITED ARAB EMIRATES CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 48 TURKEY CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 49 SAUDI ARABIA CONTRACEPTIVE MARKET 2019-2027
($ MILLION)
FIGURE 50 SOUTH AFRICA CONTRACEPTIVE MARKET 2019-2027
($ MILLION)
FIGURE 51 REST OF THE MIDDLE EAST AND AFRICA
CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)